These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 21477676)

  • 21. Rotavirus vaccines: viral shedding and risk of transmission.
    Anderson EJ
    Lancet Infect Dis; 2008 Oct; 8(10):642-9. PubMed ID: 18922486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low fecal rotavirus vaccine virus shedding is significantly associated with non-secretor histo-blood group antigen phenotype among infants in northern Pretoria, South Africa.
    Magwira CA; Kgosana LP; Esona MD; Seheri ML
    Vaccine; 2020 Dec; 38(52):8260-8263. PubMed ID: 33213928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infrequent Transmission of Monovalent Human Rotavirus Vaccine Virus to Household Contacts of Vaccinated Infants in Malawi.
    Bennett A; Pollock L; Jere KC; Pitzer VE; Lopman B; Parashar U; Everett D; Heyderman RS; Bar-Zeev N; Cunliffe NA; Iturriza-Gomara M
    J Infect Dis; 2019 May; 219(11):1730-1734. PubMed ID: 30689911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.
    Shui IM; Baggs J; Patel M; Parashar UD; Rett M; Belongia EA; Hambidge SJ; Glanz JM; Klein NP; Weintraub E
    JAMA; 2012 Feb; 307(6):598-604. PubMed ID: 22318281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of Rotavirus Nosocomial Spread After Inpatient Pentavalent Rotavirus Vaccination.
    Hofstetter AM; Lacombe K; Klein EJ; Jones C; Strelitz B; Jacobson E; Ranade D; Ward ML; Mijatovic-Rustempasic S; Evans D; Wikswo M; Bowen MD; Parashar UD; Payne DC; Englund JA
    Pediatrics; 2018 Jan; 141(1):. PubMed ID: 29212881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VP6: A candidate rotavirus vaccine.
    Ward RL; McNeal MM
    J Infect Dis; 2010 Sep; 202 Suppl():S101-7. PubMed ID: 20684688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
    García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J
    Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of rotavirus A diarrhea in Chókwè, Southern Mozambique, from February to September, 2011.
    Langa JS; Thompson R; Arnaldo P; Resque HR; Rose T; Enosse SM; Fialho A; de Assis RM; da Silva MF; Leite JP
    J Med Virol; 2016 Oct; 88(10):1751-8. PubMed ID: 27003797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland.
    Mukhopadhya I; Murdoch H; Berry S; Hunt A; Iturriza-Gomara M; Smith-Palmer A; Cameron JC; Hold GL
    Vaccine; 2017 Jan; 35(1):156-163. PubMed ID: 27876201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot study on use of live attenuated rotavirus vaccine (Rotarix™) as an infection challenge model.
    Chilengi R; Simuyandi M; Chibuye M; Chirwa M; Sukwa N; Laban N; Chisenga C; Silwamba S; Grassly N; Bosomprah S
    Vaccine; 2020 Oct; 38(46):7357-7362. PubMed ID: 33032844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Horizontal transmission of a human rotavirus vaccine strain--a randomized, placebo-controlled study in twins.
    Rivera L; Peña LM; Stainier I; Gillard P; Cheuvart B; Smolenov I; Ortega-Barria E; Han HH
    Vaccine; 2011 Nov; 29(51):9508-13. PubMed ID: 22008819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diversity of rotavirus strains circulating in Northern Brazil after introduction of a rotavirus vaccine: high prevalence of G3P[6] genotype.
    da Silva Soares L; de Fátima Dos Santos Guerra S; do Socorro Lima de Oliveira A; da Silva Dos Santos F; de Fátima Costa de Menezes EM; Mascarenhas Jd; Linhares AC
    J Med Virol; 2014 Jun; 86(6):1065-72. PubMed ID: 24136444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant administration of diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine derived from Sabin strains (DTaP-sIPV) with pentavalent rotavirus vaccine in Japanese infants.
    Tanaka Y; Yokokawa R; Rong HS; Kishino H; Stek JE; Nelson M; Lawrence J
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-7. PubMed ID: 28140752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine.
    Dennehy PH; Goveia MG; Dallas MJ; Heaton PM
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S36-42. PubMed ID: 18162245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
    Saluja T; Palkar S; Misra P; Gupta M; Venugopal P; Sood AK; Dhati RM; Shetty A; Dhaded SM; Agarkhedkar S; Choudhury A; Kumar R; Balasubramanian S; Babji S; Adhikary L; Dupuy M; Chadha SM; Desai F; Kukian D; Patnaik BN; Dhingra MS
    Vaccine; 2017 Jun; 35(28):3575-3581. PubMed ID: 28536027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-vaccine rotavirus genotype distribution in Nairobi County, Kenya.
    Gikonyo JN; Mbatia B; Okanya PW; Obiero GFO; Sang C; Steele D; Nyangao J
    Int J Infect Dis; 2020 Nov; 100():434-440. PubMed ID: 32898668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children.
    Dang DA; Nguyen VT; Vu DT; Nguyen TH; Nguyen DM; Yuhuan W; Baoming J; Nguyen DH; Le TL;
    Vaccine; 2012 Apr; 30 Suppl 1():A114-21. PubMed ID: 22520120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.
    Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
    Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
    Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.